Literature DB >> 31721239

Predicting the Probability that a Chemical Causes Steatosis Using Adverse Outcome Pathway Bayesian Networks (AOPBNs).

Lyle D Burgoon1, Michelle Angrish2, Natalia Garcia-Reyero1, Nathan Pollesch3, Anze Zupanic4, Edward Perkins1.   

Abstract

Adverse outcome pathway Bayesian networks (AOPBNs) are a promising avenue for developing predictive toxicology and risk assessment tools based on adverse outcome pathways (AOPs). Here, we describe a process for developing AOPBNs. AOPBNs use causal networks and Bayesian statistics to integrate evidence across key events. In this article, we use our AOPBN to predict the occurrence of steatosis under different chemical exposures. Since it is an expert-driven model, we use external data (i.e., data not used for modeling) from the literature to validate predictions of the AOPBN model. The AOPBN accurately predicts steatosis for the chemicals from our external data. In addition, we demonstrate how end users can utilize the model to simulate the confidence (based on posterior probability) associated with predicting steatosis. We demonstrate how the network topology impacts predictions across the AOPBN, and how the AOPBN helps us identify the most informative key events that should be monitored for predicting steatosis. We close with a discussion of how the model can be used to predict potential effects of mixtures and how to model susceptible populations (e.g., where a mutation or stressor may change the conditional probability tables in the AOPBN). Using this approach for developing expert AOPBNs will facilitate the prediction of chemical toxicity, facilitate the identification of assay batteries, and greatly improve chemical hazard screening strategies. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Adverse outcome pathway; computational toxicology; risk assessment; toxicology

Mesh:

Year:  2019        PMID: 31721239      PMCID: PMC7397752          DOI: 10.1111/risa.13423

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.302


  38 in total

Review 1.  An introduction to causal inference.

Authors:  Judea Pearl
Journal:  Int J Biostat       Date:  2010-02-26       Impact factor: 0.968

Review 2.  mTOR signaling at a glance.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  J Cell Sci       Date:  2009-10-15       Impact factor: 5.285

Review 3.  Peroxisomal beta-oxidation and steatohepatitis.

Authors:  M S Rao; J K Reddy
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

4.  Sterol regulatory element-binding protein-1 (SREBP-1) is required to regulate glycogen synthesis and gluconeogenic gene expression in mouse liver.

Authors:  Rafaela Ruiz; Victoria Jideonwo; Miwon Ahn; Sneha Surendran; Vincent S Tagliabracci; Yongyong Hou; Aisha Gamble; Janos Kerner; José M Irimia-Dominguez; Michelle A Puchowicz; Anna DePaoli-Roach; Charles Hoppel; Peter Roach; Núria Morral
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

5.  Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER.

Authors:  Wei Liao; To Y Hui; Stephen G Young; Roger A Davis
Journal:  J Lipid Res       Date:  2003-02-16       Impact factor: 5.922

6.  Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.

Authors:  Inés Pineda Torra; Thierry Claudel; Caroline Duval; Vladimir Kosykh; Jean-Charles Fruchart; Bart Staels
Journal:  Mol Endocrinol       Date:  2003-02

7.  Ablation of PI3K p110-α prevents high-fat diet-induced liver steatosis.

Authors:  Mohar Chattopadhyay; Elzbieta S Selinger; Lisa M Ballou; Richard Z Lin
Journal:  Diabetes       Date:  2011-04-04       Impact factor: 9.461

Review 8.  The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.

Authors:  Sílvia S Chambel; Andreia Santos-Gonçalves; Tiago L Duarte
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

9.  Using ToxCast™ Data to Reconstruct Dynamic Cell State Trajectories and Estimate Toxicological Points of Departure.

Authors:  Imran Shah; R Woodrow Setzer; John Jack; Keith A Houck; Richard S Judson; Thomas B Knudsen; Jie Liu; Matthew T Martin; David M Reif; Ann M Richard; Russell S Thomas; Kevin M Crofton; David J Dix; Robert J Kavlock
Journal:  Environ Health Perspect       Date:  2015-10-16       Impact factor: 9.031

Review 10.  Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes.

Authors:  Carsten Schmitz-Peiffer; Trevor J Biden
Journal:  Diabetes       Date:  2008-07       Impact factor: 9.461

View more
  5 in total

Review 1.  Quantitative adverse outcome pathway (qAOP) models for toxicity prediction.

Authors:  Nicoleta Spinu; Mark T D Cronin; Steven J Enoch; Judith C Madden; Andrew P Worth
Journal:  Arch Toxicol       Date:  2020-05-18       Impact factor: 5.153

2.  Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network.

Authors:  Nicoleta Spînu; Mark T D Cronin; Junpeng Lao; Anna Bal-Price; Ivana Campia; Steven J Enoch; Judith C Madden; Liadys Mora Lagares; Marjana Novič; David Pamies; Stefan Scholz; Daniel L Villeneuve; Andrew P Worth
Journal:  Comput Toxicol       Date:  2022-02

3.  From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study.

Authors:  Živa Ramšak; Vid Modic; Roman A Li; Colette Vom Berg; Anze Zupanic
Journal:  Front Toxicol       Date:  2022-03-07

4.  From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration.

Authors:  Dennis Sinitsyn; Natàlia Garcia-Reyero; Karen H Watanabe
Journal:  Front Toxicol       Date:  2022-03-30

5.  Deriving time-concordant event cascades from gene expression data: A case study for Drug-Induced Liver Injury (DILI).

Authors:  Anika Liu; Namshik Han; Jordi Munoz-Muriedas; Andreas Bender
Journal:  PLoS Comput Biol       Date:  2022-06-10       Impact factor: 4.779

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.